This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Musher, B.
Right arrow Articles by Marr, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Musher, B.
Right arrow Articles by Marr, K. A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, December 2004, p. 5517-5522, Vol. 42, No. 12
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.12.5517-5522.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Aspergillus Galactomannan Enzyme Immunoassay and Quantitative PCR for Diagnosis of Invasive Aspergillosis with Bronchoalveolar Lavage Fluid

Benjamin Musher,1 David Fredricks,1,2 Wendy Leisenring,1,2 S. Arunmozhi Balajee,2 Caitlin Smith,1 and Kieren A. Marr1,2*

University of Washington,1 Fred Hutchinson Cancer Research Center, Seattle, Washington2

Received 2 April 2004/ Returned for modification 13 June 2004/ Accepted 3 August 2004

Invasive pulmonary aspergillosis (IPA) is frequent and often fatal in hematopoietic stem cell transplant patients. Diagnosis requires microbiological or histopathologic demonstration of the organism in tissues; however, cultivation of Aspergillus species from respiratory secretions has low diagnostic sensitivity. Assays to detect Aspergillus antigen or DNA in bronchoalveolar lavage (BAL) fluid could facilitate earlier diagnosis, thereby guiding optimal therapy and obviating the need for additional costly and potentially morbid diagnostic evaluation. We evaluated the performance of a galactomannan enzyme immunoassay (GM EIA; Bio-Rad) by using a range of index cutoffs to define positivity and a quantitative PCR (qPCR) assay for the detection of Aspergillus species from BAL samples of patients with proven and probable IPA (case patients; n = 49) and without IPA (control patients; n = 50). The sensitivity of the GM EIA was 61% with an index cutoff of 1.0 and 76% with an index cutoff of 0.5; the corresponding specificities were 98 and 94%, respectively. The sensitivity and specificity of qPCR assay were 67 and 100%, respectively. The sensitivity with 22 culture-negative BAL specimens from patients with IPA was 41% for GM EIA with an index cutoff of 1.0, 59% for GM EIA with an index cutoff of 0.5, and 36% for qPCR assay. GM EIA indices and DNA quantities corresponded to BAL fungal burdens, with culture-positive samples having larger amounts of antigen and DNA compared to culture-negative samples. GM EIA and qPCR assay add to the sensitivity of BAL for diagnosing IPA in high-risk patients, with excellent specificity. Adjunctive use of these tests may reduce dependence on invasive diagnostic procedures.

* Corresponding author. Mailing address: Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N. D3-100, Seattle, WA 98109. Phone: (206) 667-6702. Fax: (206) 667-4411. E-mail: kmarr{at}fhcrc.org.

Journal of Clinical Microbiology, December 2004, p. 5517-5522, Vol. 42, No. 12
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.12.5517-5522.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Barnes, R A, White, P L, Bygrave, C, Evans, N, Healy, B, Kell, J (2009). Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients. J. Clin. Pathol. 62: 64-69 [Abstract] [Full Text]  
  • Husain, S., Clancy, C. J., Nguyen, M. H., Swartzentruber, S., Leather, H., LeMonte, A. M., Durkin, M. M., Knox, K. S., Hage, C. A., Bentsen, C., Singh, N., Wingard, J. R., Wheat, L. J. (2008). Performance Characteristics of the Platelia Aspergillus Enzyme Immunoassay for Detection of Aspergillus Galactomannan Antigen in Bronchoalveolar Lavage Fluid. CVI 15: 1760-1763 [Abstract] [Full Text]  
  • Vallor, A. C., Kirkpatrick, W. R., Najvar, L. K., Bocanegra, R., Kinney, M. C., Fothergill, A. W., Herrera, M. L., Wickes, B. L., Graybill, J. R., Patterson, T. F. (2008). Assessment of Aspergillus fumigatus Burden in Pulmonary Tissue of Guinea Pigs by Quantitative PCR, Galactomannan Enzyme Immunoassay, and Quantitative Culture. Antimicrob. Agents Chemother. 52: 2593-2598 [Abstract] [Full Text]  
  • Penack, O., Rempf, P., Graf, B., Blau, I. W., Thiel, E. (2008). Aspergillus galactomannan testing in patients with long-term neutropenia: implications for clinical management. Ann Oncol 19: 984-989 [Abstract] [Full Text]  
  • Samarakoon, P., Soubani, A. (2008). Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature. Chronic Respiratory Disease 5: 19-27 [Abstract]  
  • Barnes, R. A. (2008). Early diagnosis of fungal infection in immunocompromised patients. J Antimicrob Chemother 61: i3-i6 [Abstract] [Full Text]  
  • Bulpa, P., Dive, A., Sibille, Y. (2007). Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J 30: 782-800 [Abstract] [Full Text]  
  • Kostamo, K., Richardson, M., Eerola, E., Rantakokko-Jalava, K., Meri, T., Malmberg, H., Toskala, E. (2007). Negative impact of Aspergillus galactomannan and DNA detection in the diagnosis of fungal rhinosinusitis. J Med Microbiol 56: 1322-1327 [Abstract] [Full Text]  
  • Nguyen, M. H., Jaber, R., Leather, H. L., Wingard, J. R., Staley, B., Wheat, L. J., Cline, C. L., Baz, M., Rand, K. H., Clancy, C. J. (2007). Use of Bronchoalveolar Lavage To Detect Galactomannan for Diagnosis of Pulmonary Aspergillosis among Nonimmunocompromised Hosts. J. Clin. Microbiol. 45: 2787-2792 [Abstract] [Full Text]  
  • Zmeili, O.S., Soubani, A.O. (2007). Pulmonary aspergillosis: a clinical update. QJM 100: 317-334 [Abstract] [Full Text]  
  • Clancy, C. J., Jaber, R. A., Leather, H. L., Wingard, J. R., Staley, B., Wheat, L. J., Cline, C. L., Rand, K. H., Schain, D., Baz, M., Nguyen, M. H. (2007). Bronchoalveolar Lavage Galactomannan in Diagnosis of Invasive Pulmonary Aspergillosis among Solid-Organ Transplant Recipients. J. Clin. Microbiol. 45: 1759-1765 [Abstract] [Full Text]  
  • Hage, C. A., Reynolds, J. M., Durkin, M., Wheat, L. J., Knox, K. S. (2007). Plasmalyte as a Cause of False-Positive Results for Aspergillus Galactomannan in Bronchoalveolar Lavage Fluid. J. Clin. Microbiol. 45: 676-677 [Full Text]  
  • Francesconi, A., Kasai, M., Petraitiene, R., Petraitis, V., Kelaher, A. M., Schaufele, R., Hope, W. W., Shea, Y. R., Bacher, J., Walsh, T. J. (2006). Characterization and Comparison of Galactomannan Enzyme Immunoassay and Quantitative Real-Time PCR Assay for Detection of Aspergillus fumigatus in Bronchoalveolar Lavage Fluid from Experimental Invasive Pulmonary Aspergillosis.. J. Clin. Microbiol. 44: 2475-2480 [Abstract] [Full Text]  
  • Englund, J. A., Boeckh, M., Kuypers, J., Nichols, W. G., Hackman, R. C., Morrow, R. A., Fredricks, D. N., Corey, L. (2006). Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients.. ANN INTERN MED 144: 344-349 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»